Jiang Fenglin, Gong Ting, Chen Jingjing, Chen Tianjiao, Yang Jinling, Zhu Ping
NHC Key Laboratory of Biosynthesis of Natural Products, CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs, State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Sheng Wu Gong Cheng Xue Bao. 2021 Jun 25;37(6):1931-1951. doi: 10.13345/j.cjb.210138.
Medicinal natural products derived from plants are usually of low content and difficult to extract and isolate. Moreover, these compounds are structurally complex, making it difficult to obtain them by environmental unfriendly chemical synthesis. Biosynthesis of medicinal natural products through synthetic biology is a novel, environment-friendly and sustainable approach. Taking terpenoids (ginsenosides, paclitaxel, artemisinin, tanshinones), alkaloids (vincristine and morphine), and flavonoids (breviscapine) as examples, this review summarizes the advances of the biosynthetic pathways and synthetic biology strategies of plant-derived medicinal natural products. Moreover, we introduce the key technologies and methods of synthetic biology used in the research of medicinal natural products, and provide future prospects in this area.
来源于植物的药用天然产物通常含量较低,且难以提取和分离。此外,这些化合物结构复杂,难以通过对环境不友好的化学合成方法获得。通过合成生物学进行药用天然产物的生物合成是一种新颖、环保且可持续的方法。以萜类化合物(人参皂苷、紫杉醇、青蒿素、丹参酮)、生物碱(长春新碱和吗啡)以及黄酮类化合物(灯盏花素)为例,本综述总结了植物源药用天然产物生物合成途径和合成生物学策略的研究进展。此外,我们介绍了用于药用天然产物研究的合成生物学关键技术和方法,并对该领域的未来发展进行了展望。